Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity.


Maiden, MC; Ibarz-Pavón, AB; Urwin, R; Gray, SJ; Andrews, NJ; Clarke, SC; Walker, AM; Evans, MR; Kroll, JS; Neal, KR; Ala'aldeen, DA; Crook, DW; Cann, K; Harrison, S; Cunningham, R; Baxter, D; Kaczmarski, E; Maclennan, J; Cameron, JC; Stuart, JM; (2008) Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. The Journal of infectious diseases, 197 (5). pp. 737-43. ISSN 0022-1899 DOI: 10.1086/527401

Full text not available from this repository. (Request a copy)

Abstract

In 1999, meningococcal serogroup C conjugate (MCC) vaccines were introduced in the United Kingdom for those under 19 years of age. The impact of this intervention on asymptomatic carriage of meningococci was investigated to establish whether serogroup replacement or protection by herd immunity occurred.

Item Type: Article
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Disease Control
Research Centre: Vaccine Centre
PubMed ID: 18271745
Web of Science ID: 253773400020
URI: http://researchonline.lshtm.ac.uk/id/eprint/1624

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
290Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item